Clinical Trial Update: Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA [Phase 4]

View source ↗

Summary

Phase 4 trial comparing daptomycin to vancomycin for skin infections caused by MRSA has completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcal Skin Infections

Drugs mentioned

• Daptomycin (daptomycin)
• Vancomycin (vancomycin)

Snippet

Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Staphylococcal Skin Infections | Phase 4 | Status: COMPLETED | Results posted: 2015-07-08